+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Spectranetics Corp - Product Pipeline Analysis, 2018 Update

FEATURED COMPANIES

  • Abiomed Inc
  • Boston Scientific Corp
  • Utah Medical Products Inc
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

Spectranetics Corp (Spectranetics) is a medical device company that manufactures and distributes disposable medical devices. The company provides peripheral intervention, lead management and coronary intervention products. It offers peripheral and cardiac laser catheters for ablation of stenosed and occluded arteries. Spectranetics also offers coronary laser atherectomy catheters, scoring balloon catheter, excimer laser system, extraction catheter and support catheters. The company offers training and support services. It develops its products for treating cardiovascular diseases. The company serves physicians, patients and hospitals. It has operations in the Netherlands, France, Denmark, Germany, Austria, Australia and the UK. Spectranetics is headquartered in Colorado Springs, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Spectranetics Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abiomed Inc
  • Boston Scientific Corp
  • Utah Medical Products Inc
  • MORE

Spectranetics Corp Company Overview
Spectranetics Corp Company Snapshot

Spectranetics Corp Pipeline Products and Ongoing Clinical Trials Overview
Spectranetics Corp – Pipeline Analysis Overview
Spectranetics Corp - Key Facts
Spectranetics Corp - Major Products and Services
Spectranetics Corp Pipeline Products by Development Stage
Spectranetics Corp Ongoing Clinical Trials by Trial Status
Spectranetics Corp Pipeline Products Overview
CardioSculpt Valvuloplasty Scoring Balloon
CardioSculpt Valvuloplasty Scoring Balloon Product Overview
Drug Coated Balloon - In-stent Restenosis (ISR)
Drug Coated Balloon - In-stent Restenosis (ISR) Product Overview
Nexcimer
Nexcimer Product Overview
Next Gen Lead Management (LM) Tool
Next Gen Lead Management (LM) Tool Product Overview
Next-Gen Atherectomy Device
Next-Gen Atherectomy Device Product Overview
Next-gen Mechanical Tool
Next-gen Mechanical Tool Product Overview
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK)
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) Product Overview
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) Clinical Trial
Stellarex Drug Coated Balloon - Above-The-Knee
Stellarex Drug Coated Balloon - Above-The-Knee Product Overview
Stellarex Drug Coated Balloon - Above-The-Knee Clinical Trial

Spectranetics Corp - Key Competitors

Spectranetics Corp - Key Employees

Spectranetics Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments

Spectranetics Corp, Recent Developments
Sep 14, 2017: Efficacy of Philips' Stellarex .035 low-dose drug-coated balloon demonstrated in clinical trial at two years
Sep 13, 2017: New Unpublished Vascular Clinical Trial Results on drug-coated balloons Presented at VIVA 17
Sep 13, 2017: New Unpublished Clinical Trial Results of Stellarex DCB Announced At VIVA 17
Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million
Jul 26, 2017: Spectranetics Announces FDA Approval of Stellarex Drug-Coated Balloon
Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors
Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million
Feb 23, 2017: Spectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million
Jan 24, 2017: ILLUMENATE Global 12-month Results Validate Stellarex’s Top-tier Performance in Complex Patient Populations
Jan 11, 2017: Spectranetics Names Scott Hutton as General Manager, Vascular Intervention

Appendix
Methodology
About
Contact Us
Disclaimer

List of Tables
Spectranetics Corp Pipeline Products and Ongoing Clinical Trials Overview
Spectranetics Corp Pipeline Products by Equipment Type
Spectranetics Corp Pipeline Products by Indication
Spectranetics Corp Ongoing Clinical Trials by Trial Status
Spectranetics Corp, Key Facts
Spectranetics Corp, Major Products and Services
Spectranetics Corp Number of Pipeline Products by Development Stage
Spectranetics Corp Pipeline Products Summary by Development Stage
Spectranetics Corp Ongoing Clinical Trials by Trial Status
Spectranetics Corp Ongoing Clinical Trials Summary
CardioSculpt Valvuloplasty Scoring Balloon - Product Status
CardioSculpt Valvuloplasty Scoring Balloon - Product Description
Drug Coated Balloon - In-stent Restenosis (ISR) - Product Status
Drug Coated Balloon - In-stent Restenosis (ISR) - Product Description
Nexcimer - Product Status
Nexcimer - Product Description
Next Gen Lead Management (LM) Tool - Product Status
Next Gen Lead Management (LM) Tool - Product Description
Next-Gen Atherectomy Device - Product Status
Next-Gen Atherectomy Device - Product Description
Next-gen Mechanical Tool - Product Status
Next-gen Mechanical Tool - Product Description
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) - Product Status
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) - Product Description
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) - Prospective, Randomized, Multi-center Study to Evaluate Treatment of Subjects with Occlusive Disease with a Novel Paclitaxel-coated Angioplasty Balloon in Below-The-Knee (BTK) Arteries - ILLUMENATE BTK
Stellarex Drug Coated Balloon - Above-The-Knee - Product Status
Stellarex Drug Coated Balloon - Above-The-Knee - Product Description
Stellarex Drug Coated Balloon - Above-The-Knee - Economic Evaluation Comparing Standard Balloon Angioplasty Versus Drug-eluted Balloon or Laser-excimer in Association with Drug-eluted Balloon in the Treatment of Femoropopliteal Artery In-stent Restenosis
Stellarex Drug Coated Balloon - Above-The-Knee - Prospective, Randomized, Single-blind, U.S. Multi-center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery or Popliteal Lesions with a Novel Paclitaxel-coated Percutaneous Angioplasty Balloon: ILLUMENATE Pivotal
Stellarex Drug Coated Balloon - Above-The-Knee - Prospective, Single-arm, Global Multi-center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery (SFA) and/or Popliteal Lesions with a Novel Paclitaxel-coated Percutaneous Angioplasty (PTA) Balloon and in In-Stent Restenosis: ILLUMENATE GLOBAL and ISR
Stellarex Drug Coated Balloon - Above-The-Knee - Stellarex Vascular E-Registry
Spectranetics Corp, Key Employees
Spectranetics Corp, Other Locations
Spectranetics Corp, Subsidiaries
Glossary

List of Figures
Spectranetics Corp Pipeline Products by Equipment Type
Spectranetics Corp Pipeline Products by Development Stage
Spectranetics Corp Ongoing Clinical Trials by Trial Status

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Boston Scientific Corp
  • Utah Medical Products Inc
  • Abiomed Inc
Note: Product cover images may vary from those shown
Adroll
adroll